PubMed · 2007 · 48 citations · 11 references
Veterinary MedicineImmunologyInfectious DiseasesHiv PreventionImmunizationVaccinologyAntiretroviral TherapyClinical Trial EthicsClinical TrialsClinical Vaccine TrialsVaccinationVaccine EfficacyClinical Trial Participation DisparitiesEquitable Access To TrialsPreventive Hiv Vaccines
BACKGROUND: AIDS is still a major cause of death. To combat this disease, researchers are developing a vaccine. Although blacks account for most new infections in the United States, they account for a low percent of experimental vaccine recipients. This study, conducted in a mid-sized U.S. city where vaccine trials are held, seeks to learn why. METHODS: We conducted 11 in-depth ethnographic interviews. Two groups were targeted: blacks who had not participated in HIV vaccine trials and blacks who had. RESULTS: Overall, three major causes of nonparticipation were identified: misinformation, fear/mistrust and stigma. Factors that favored participation included having close friends with HIV and being homosexual. CONCLUSIONS: HIV is considered by many blacks to be a gay, white disease. Steps to increase participation must include efforts to destigmatize the condition and disseminate accurate information. Efforts to address historical causes of mistrust through "education" alone are insufficient. Trust needs to be earned through long-term relationships with black communities.
11
Effects of Human Growth Hormone in Men over 60 Years Old
Daniel Rudman, Axel G. Feller, Hoskote S. Nagraj et al. · New England Journal of Medicine · 1990 · 1.6K citations · Full text